封面
市场调查报告书
商品编码
2008020

生物製药一次性产品市场:依产品类型、最终用户和地区划分

Single Use Products in Biopharmaceuticals Market, By Product Type, By End User, By Geography

出版日期: | 出版商: Coherent Market Insights | 英文 152 Pages | 商品交期: 2-3个工作天内

价格
简介目录

2026年一次性生物製药产品的市场规模估计为217亿美元,预计到2033年将达到344亿美元。预计从2026年到2033年,其复合年增长率将达到11.7%。

报告范围 报告详情
基准年: 2025 2026年市场规模: 217亿美元
历史数据时期: 2020年至2024年 预测期: 2026年至2033年
2026年至2033年预测期间的复合年增长率: 11.70% 2033年市场规模预测: 344亿美元

生物製药生产过程中使用的一次性产品是指使用一次后即被丢弃,不能重复用于生产的产品。这些一次性产品通常使用塑胶、聚乙烯和纸张等材料製造过滤装置。一次性产品能够降低昂贵设备的成本和细胞培养过程中的污染风险,并缩短生产时间,减少测试、验证和文件编制工作。在药物研发、疫苗生产和其他医疗创新推动下,全球生物製药市场正快速成长,预计这将进一步推动生物製药生产过程中所需一次性产品的市场需求。

市场动态

市场参与者正透过与其他公司合作,扩大其在一次性生物製药产品市场的份额,预计这将进一步推动全球一次性生物製药产品市场在预测期内的成长。例如,2021年9月9日,治疗药物研发和生产技术及服务提供者Cytiva决定扩大其在中国的一次性生物製药产品产能。透过与医疗技术供应商Wego Pharmaceutical Co.的合作,Cytiva在亚太地区的一次性产品供给能力将增加两倍。

医药市场研发和投资活动的不断增加正在推动对一次性产品的需求,预计这将促进全球一次性生物製药市场在预测期内的成长。例如,根据印度品牌股权基金会(IBEF)于2021年12月7日发布的数据,印度政府正在为製药业提供政策支援。印度财政部于2021年6月宣布,将在未来五年内提供265.783亿美元扩大研发活动。

本次调查的主要特点。

  • 本报告对全球一次性生物製药市场进行了详细分析,给出了预测期(2026-2033 年)的市场规模(以十亿美元计)和复合年增长率(CAGR%),其中 2025 年为基准年。
  • 本报告指出了各个细分市场的潜在商机,并说明了该市场中具有吸引力的投资提案矩阵。
  • 此外,本研究还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、区域前景以及主要企业采取的竞争策略的重要见解。
  • 本报告根据以下参数分析了全球一次性生物製药市场的主要企业:公司概况、财务绩效、产品系列、企业发展区域、分销策略、关键发展和策略以及未来计划。
  • 透过利用本报告中提出的见解,企业行销负责人和经营团队可以就未来的产品发布、技术升级、市场扩张和行销策略做出明智的决策。
  • 本报告面向该产业的各类相关人员,包括投资者、供应商、製造商、经销商、新参与企业和金融分析师。
  • 透过各种策略矩阵分析全球生物製药一次性产品市场,相关人员将能够更轻鬆地做出决策。

目录

第一章:研究目标与前提条件

  • 研究目标
  • 前提
  • 简称

第二章 市场概览

  • 报告摘要
    • 市场定义和范围
  • 执行摘要
  • Coherent Opportunity Map(COM)

第三章:市场动态、监管与趋势分析

  • 市场动态
    • 促进因素
    • 阻碍因素
    • 市场机会
  • 影响分析
  • 法规环境
  • PEST分析
  • 近期产品发布及核准
  • 流行病学
  • 併购

第四章 全球生物製药一次性产品市场:依产品类型划分,2026-2033年

  • 工作设备
  • 装置

第五章 全球生物製药一次性产品市场:依最终用户划分,2026-2033年

  • 製药公司
  • 生技公司
  • 研究机构

第六章 全球生物製药一次性产品市场:依地区划分,2026-2033年

  • 北美洲
    • 我们
    • 加拿大
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 其他拉丁美洲
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他欧洲国家
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 澳洲
    • 韩国
    • ASEAN
    • 亚太其他地区
  • 中东
    • GCC
    • 以色列
    • 其他中东国家
  • 非洲
    • 南非
    • 中非
    • 北非

第七章 竞争情势

  • 公司简介
    • Aber instruments
    • Adolf Kuhner AG
    • Thermo Fisher Scientific
    • Bio-equip
    • Pall corp
    • C-Cit Sensors AG
    • Corning Life Sciences
    • Eppendorf
    • GE Healthcare
    • Gemu GmbH
    • Merck
    • Avantor
    • Meissner
    • New Horizon Biotech
    • PBS-Biotech
    • Xcellerex
    • Single Use Support GmbH.

第八章

  • 参考
  • 调查方法
简介目录
Product Code: CMI4903

Single Use Products In Biopharmaceuticals Market is estimated to be valued at USD 21.7 Bn in 2026 and is expected to reach USD 34.4 Bn by 2033, growing at a compound annual growth rate (CAGR) of 11.7% from 2026 to 2033.

Report Coverage Report Details
Base Year: 2025 Market Size in 2026: USD 21.7 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2026 To 2033
Forecast Period 2026 to 2033 CAGR: 11.70% 2033 Value Projection: USD 34.4 Bn

Single use products used in biopharmaceutical manufacturing process can refer to a product that is used only once and then discard, these single use products cannot be reused for processing purposes. The materials used for manufacturing these single use products are plastic, polyethylene, paper for filtration unit. Single use products reduces the expenses of high cost equipment, risk of contamination in cell culture, reducing the time, testing, validation, and documentation of manufacturing product. As biopharmaceutical market is booming globally for drug development, vaccine production, and other medicinal innovations, this is expected to drive the market of single use products required in biopharmaceutical processing.

Market Dynamics

Market players are expanding their single use products in biopharmaceuticals market with collaborations with other companies, which is further expected to drive growth of the global single use products in biopharmaceuticals market over the forecast period. For instance, on September 9, 2021, Cytiva, a provider of technologies and services used in development and manufacture in therapeutics, decided to expand its manufacturing capacity of single use product in biopharmaceutical in China. In collaboration with Wego Pharmaceutical Co., which is a supplier of healthcare technologies will triple the supply capacity of single use product in Asia Pacific by Cytiva.

The increasing research and development, investment activities in pharmaceutical market increases the requirement of single use products and this is expected to drive growth of the global single use products in biopharmaceuticals market over the forecast period. For instance, According to India Brand Equity Foundation (IBEF) data published on December 7, 2021, in which reports that the Indian government has provided policy assistance to the pharmaceutical business, with the Ministry of Finance of India announcing US$ 26,578.3 million in financing for the next five years to increase research and development operations in June 2021.

Key features of the study

  • This report provides an in-depth analysis of global single use products in biopharmaceutical market, provides market size (USD Bn), and compound annual growth rate (CAGR %) for the forecast period (2026-2033), considering 2025 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrix for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategies adopted by the leading players
  • It profiles leading players in the global single use products in biopharmaceutical market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies, and future plans
  • Key companies covered as a part of this study include Aber instruments, Adolf Kuhner AG, Thermo Fisher Scientific, Bio-equip, Pall corp., C-Cit Sensors AG, Corning Life Sciences, Eppendorf, GE Healthcare, Gemu GmbH, Merck, Avantor , Meissner, New Horizon Biotech, PBS-Biotech, Xcellerex, and Single Use Support GmbH.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launch, technology up-gradation, market expansion, and marketing tactics
  • The global single use products in biopharmaceutical market report caters to various stakeholders in this industry including investors, suppliers, manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global single use products in biopharmaceutical market

Market Segmentation

  • By Product Type
    • Work Equipment
    • Flask
    • Containers
    • Syringes
    • Pipettes tips
    • Centrifuge tubes
    • Hand Gloves
    • Face Mask
    • Filters
    • Tubes
    • Others
    • Apparatus
    • Single Use Bioreactor
    • Isolators
    • Membrane Valves
    • Canister
    • Chromatography Systems
    • Filtration Systems
    • Mixing Systems
    • Others
  • By End User
    • Pharmaceutical Companies
    • Biotechnology Companies and Research Institutes
  • By Regional Insights
    • North America
    • U.S.
    • Canada
    • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
    • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
    • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
    • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
    • Africa
    • South Africa
    • North Africa
    • Central Africa
  • Key Players Insights
    • Aber instruments
    • Adolf Kuhner AG
    • Thermo Fisher Scientific
    • Bio-equip
    • Pall corp.
    • C-Cit Sensors AG
    • Corning Life Sciences
    • Eppendorf
    • GE Healthcare
    • Gemu GmbH
    • Merck
    • Avantor
    • Meissner
    • New Horizon Biotech
    • PBS-Biotech
    • Xcellerex
    • Single Use Support GmbH.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Overview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Product Type
    • Market Snippet, By End User
    • Market Snippet, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Impact Analysis
  • Regulatory Scenario
  • PEST Analysis
  • Recent Product Launch/Approval
  • Epidemiology
  • Mergers and Acquisitions

4. Global Single Use Products in Biopharmaceuticals Market, By Product Type, 2026-2033 (USD Bn)

  • Introduction
    • Market Share Analysis, 2025, 2028, and 2033 (%)
    • Y-o-Y Growth Analysis, 2021-2033
    • Segment Trends
  • Work Equipment
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
      • Flask
      • Containers
      • Syringes
      • Pipettes Tips
      • Centrifuge Tubes
      • Hand Gloves
      • Face Mask
      • Filters
      • Tubes
      • Others
  • Apparatus
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
      • Single Use Bioreactor
      • Isolators
      • Membrane Valves
      • Canister
      • Chromatography Systems
      • Filtration Systems
      • Mixing Systems
      • Others

5. Global Single Use Products in Biopharmaceuticals Market, By End User, 2026-2033 (USD Bn)

  • Introduction
    • Market Share Analysis, 2025, 2028, and 2033 (%)
    • Y-o-Y Growth Analysis, 2021-2033
    • Segment Trends
  • Pharmaceutical Companies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Biotechnology Companies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Research Institutes
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)

6. Global Single Use Products in Biopharmaceuticals Market, By Region, 2026-2033 (USD Bn)

  • Introduction
    • Market Share Analysis, By Region, 2025, 2028, and 2033 (%)
    • Y-o-Y Growth Analysis, For Regions, 2021-2033
    • Regional Trends
  • North America
    • Market Size and Forecast, By Product Type, 2021-2033 (USD Bn)
    • Market Size and Forecast, By End User, 2021-2033 (USD Bn)
    • Market Size and Forecast, By Country, 2021-2033 (USD Bn)
      • U.S.
      • Canada
  • Latin America
    • Market Size and Forecast, By Product Type, 2021-2033 (USD Bn)
    • Market Size and Forecast, By End User, 2021-2033 (USD Bn)
    • Market Size and Forecast, By Country, 2021-2033 (USD Bn)
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
  • Europe
    • Market Size and Forecast, By Product Type, 2021-2033 (USD Bn)
    • Market Size and Forecast, By End User, 2021-2033 (USD Bn)
    • Market Size and Forecast, By Country, 2021-2033 (USD Bn)
      • Germany
      • U.K.
      • France
      • Italy
      • Spain
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Market Size and Forecast, By Product Type, 2021-2033 (USD Bn)
    • Market Size and Forecast, By End User, 2021-2033 (USD Bn)
    • Market Size and Forecast, By Country, 2021-2033 (USD Bn)
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
  • Middle East
    • Market Size and Forecast, By Product Type, 2021-2033 (USD Bn)
    • Market Size and Forecast, By End User, 2021-2033 (USD Bn)
    • Market Size and Forecast, By Country, 2021-2033 (USD Bn)
      • GCC
      • Israel
      • Rest of Middle East
  • Africa
    • Market Size and Forecast, By Product Type, 2021-2033 (USD Bn)
    • Market Size and Forecast, By End User, 2021-2033 (USD Bn)
    • Market Size and Forecast, By Country, 2021-2033 (USD Bn)
      • South Africa
      • Central Africa
      • North Africa

7. Competitive Landscape

  • Company Profiles
    • Aber instruments
      • Company Overview
      • Drug Portfolio
      • Financial Performance
      • Recent Developments/Updates
      • Strategies
    • Adolf Kuhner AG
      • Company Overview
      • Drug Portfolio
      • Financial Performance
      • Recent Developments/Updates
      • Strategies
    • Thermo Fisher Scientific
      • Company Overview
      • Drug Portfolio
      • Financial Performance
      • Recent Developments/Updates
      • Strategies
    • Bio-equip
      • Company Overview
      • Drug Portfolio
      • Financial Performance
      • Recent Developments/Updates
      • Strategies
    • Pall corp
      • Company Overview
      • Drug Portfolio
      • Financial Performance
      • Recent Developments/Updates
      • Strategies
    • C-Cit Sensors AG
      • Company Overview
      • Drug Portfolio
      • Financial Performance
      • Recent Developments/Updates
      • Strategies
    • Corning Life Sciences
      • Company Overview
      • Drug Portfolio
      • Financial Performance
      • Recent Developments/Updates
      • Strategies
    • Eppendorf
      • Company Overview
      • Drug Portfolio
      • Financial Performance
      • Recent Developments/Updates
      • Strategies
    • GE Healthcare
      • Company Overview
      • Drug Portfolio
      • Financial Performance
      • Recent Developments/Updates
      • Strategies
    • Gemu GmbH
      • Company Overview
      • Drug Portfolio
      • Financial Performance
      • Recent Developments/Updates
      • Strategies
    • Merck
      • Company Overview
      • Drug Portfolio
      • Financial Performance
      • Recent Developments/Updates
      • Strategies
    • Avantor
      • Company Overview
      • Drug Portfolio
      • Financial Performance
      • Recent Developments/Updates
      • Strategies
    • Meissner
      • Company Overview
      • Drug Portfolio
      • Financial Performance
      • Recent Developments/Updates
      • Strategies
    • New Horizon Biotech
      • Company Overview
      • Drug Portfolio
      • Financial Performance
      • Recent Developments/Updates
      • Strategies
    • PBS-Biotech
      • Company Overview
      • Drug Portfolio
      • Financial Performance
      • Recent Developments/Updates
      • Strategies
    • Xcellerex
      • Company Overview
      • Drug Portfolio
      • Financial Performance
      • Recent Developments/Updates
      • Strategies
    • Single Use Support GmbH.
      • Company Overview
      • Drug Portfolio
      • Financial Performance
      • Recent Developments/Updates
      • Strategies
      • Analyst Views

8. Section

  • References
  • Research Methodology
  • About us and Sales Contact